MX2021001082A - Mezclas de cetoacidos de cadena ramificada (bcka) y metodo para la produccion de tales mezclas. - Google Patents

Mezclas de cetoacidos de cadena ramificada (bcka) y metodo para la produccion de tales mezclas.

Info

Publication number
MX2021001082A
MX2021001082A MX2021001082A MX2021001082A MX2021001082A MX 2021001082 A MX2021001082 A MX 2021001082A MX 2021001082 A MX2021001082 A MX 2021001082A MX 2021001082 A MX2021001082 A MX 2021001082A MX 2021001082 A MX2021001082 A MX 2021001082A
Authority
MX
Mexico
Prior art keywords
keto acids
mixtures
production
branched chain
chain keto
Prior art date
Application number
MX2021001082A
Other languages
English (en)
Inventor
Christine Jarecki
Dieter Feit
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Publication of MX2021001082A publication Critical patent/MX2021001082A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a un proceso para la producción de una mezcla homogénea de dos o más cetoácidos de cadena ramificada, en donde en una primera etapa, se mezclan dos o más cetoácidos libres, y en una segunda etapa, los cetoácidos mezclados se co-cristalizan con una o más sales de metales alcalinotérreos, y un producto alimenticio, suplemento alimenticio o productos farmacéuticos que contienen una mezcla de cetoácidos de cadena ramificada para soportar la estructura muscular, aumentando el rendimiento muscular y mejorando el bienestar general con alivio simultáneo de metabolismo de destoxificación de nitrógeno mediante un suministro de nitrógeno reducido en comparación con la ingestión de los aminoácidos correspondientes y un metabolismo de nitrógeno mejorado en el cuerpo.
MX2021001082A 2018-07-31 2019-07-26 Mezclas de cetoacidos de cadena ramificada (bcka) y metodo para la produccion de tales mezclas. MX2021001082A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18186513.0A EP3603419B1 (en) 2018-07-31 2018-07-31 Mixtures of branched chain keto acids (bcka) and method for the production of such mixtures
PCT/EP2019/070223 WO2020025489A1 (en) 2018-07-31 2019-07-26 Mixtures of branched chain keto acids (bcka) and method for the production of such mixtures

Publications (1)

Publication Number Publication Date
MX2021001082A true MX2021001082A (es) 2021-03-31

Family

ID=63293903

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001082A MX2021001082A (es) 2018-07-31 2019-07-26 Mezclas de cetoacidos de cadena ramificada (bcka) y metodo para la produccion de tales mezclas.

Country Status (13)

Country Link
US (1) US11642314B2 (es)
EP (2) EP3603419B1 (es)
JP (1) JP7394076B2 (es)
KR (1) KR102629192B1 (es)
CN (1) CN112512339A (es)
AU (1) AU2019314671A1 (es)
BR (1) BR112021001747A2 (es)
CA (1) CA3107652A1 (es)
DK (1) DK3603419T3 (es)
ES (1) ES2882278T3 (es)
MX (1) MX2021001082A (es)
PL (1) PL3603419T3 (es)
WO (1) WO2020025489A1 (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100293A (en) 1974-04-15 1978-07-11 The Johns Hopkins University Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids
GB1511302A (en) 1974-04-15 1978-05-17 Univ Johns Hopkins Pharmaceutical compositions comprising amino acid analogues
US4677121A (en) 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US6100287A (en) 1997-11-13 2000-08-08 University Of Florida Materials and methods for enhancing muscle performance and recovery from fatigue
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
DE102007016715A1 (de) 2007-04-04 2008-10-09 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren
JPWO2010050168A1 (ja) 2008-10-27 2012-03-29 味の素株式会社 バリン、イソロイシン、ロイシン固溶体およびその製造方法
DE102009016119A1 (de) 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
CN101991570B (zh) 2009-08-14 2014-06-18 上海秀新臣邦医药科技有限公司 稳定的复方酮酸制剂及其制备方法
CN102988357B (zh) 2011-09-14 2014-05-21 北大方正集团有限公司 一种复方α酮酸药物组合物及其制备方法

Also Published As

Publication number Publication date
EP3603419A1 (en) 2020-02-05
US11642314B2 (en) 2023-05-09
DK3603419T3 (da) 2021-09-13
CA3107652A1 (en) 2020-02-06
US20210290544A1 (en) 2021-09-23
PL3603419T3 (pl) 2021-12-06
WO2020025489A1 (en) 2020-02-06
ES2882278T3 (es) 2021-12-01
KR20210038595A (ko) 2021-04-07
KR102629192B1 (ko) 2024-01-29
BR112021001747A2 (pt) 2021-04-27
AU2019314671A1 (en) 2021-03-18
EP3829324B1 (en) 2022-09-07
JP2021532737A (ja) 2021-12-02
CN112512339A (zh) 2021-03-16
JP7394076B2 (ja) 2023-12-07
EP3829324A1 (en) 2021-06-09
EP3603419B1 (en) 2021-06-16

Similar Documents

Publication Publication Date Title
Soares et al. Dietary amino acids and immunonutrition supplementation in cancer-induced skeletal muscle mass depletion: a mini-review
PH12018502169A1 (en) Extraction method
SG163600A1 (en) Methods for the treatment of muscle loss
PH12018501988A1 (en) Agent for increasing intestinal butyric acid and proliferation agent for butyric acid-producing bacteria
EP4218751A3 (en) Dietary product devoid of at least two non essential amino acid
RU2009118575A (ru) Долговременное питание для больного раком
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
MX2021010208A (es) Metodos que usan trigliceridos de cadena media administrados antes de una comida para reducir la glucosa postprandial generada por la comida.
MX2021013030A (es) Cepas bacterianas probioticas que producen acidos grasos de cadena corta y composiciones que las comprenden.
Hong et al. Performance of growing period of large-type Korean native ducks
MX2021001082A (es) Mezclas de cetoacidos de cadena ramificada (bcka) y metodo para la produccion de tales mezclas.
PH12020500074A1 (en) Peptide
MX2020005304A (es) Procedimiento para la produccion de un aditivo multiplicador y modulador de la microbiota ruminal.
MX346571B (es) Fortificacion de calcio de masa de pan.
RU2008126860A (ru) Способ повышения продуктивности и качества продукции овцеводства
MX2018007529A (es) Composiciones de proteina vegetal fermentada y métodos para su producción.
CN103621838A (zh) 提高初产期鸭蛋蛋重的鸭用预混料及其使用方法
Sun et al. Absorption of iron from Tegillarca granosa using an in vitro simulated digestion and Caco‐2/HepG2 co‐culture system
Manary Protein source and quality in therapeutic foods affect the immune response and outcome in severe acute malnutrition
MX2016016313A (es) Sumplemento alimenticio a base de ferulato de etilo.
Herrera et al. Calcium as a nutrient involved in the synthesis and localization of proteins that facilitate iron uptake and effl ux in enterocytes
MX2022012655A (es) Complementos y composiciones que contienen aminoacidos e igf-1 y metodos de uso.
Ojalvo et al. The safety and absorption of magnesium biotinate in rats (P06-029-19)
MX2022014158A (es) Metodos que reducen los antojos de alimentos, promueven la perdida de peso y/o tratan el sobrepeso o la obesidad.
MX2022004516A (es) Metodo y composicion para aumentar la sintesis de proteinas musculares.